14 results
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 ... and Titration Algorithm ... Established ASCVD or CKD ... #Diabetes #DM2 ... #Type2 #Medication
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Improved outcomes in CKD ... EricsMedicalLectures/featured #diabetes ... medications #table #comparison ... endocrinology #dm2
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Type 2 Diabetes ... and Management Algorithm ... relative with DM2 ... Cushing Syndrome, PCOS ... Targets #Management #algorithm
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Insulin deficit: - Type ... I DM: No insulin ... produced - Type ... II DM pts under ... pathophysiology #comparison
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... ml/min per 1.73 m2 ... patients with Type ... 1 diabetes or Type ... #Diabetes #CKD #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient ... basal insulin in Type ... glucose monitors in Type ... #Mellitus #DM2 ... #pharmacology #comparison
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
(stage IV or V CKD ... including most type ... 1 diabetics • ... endocrinology #diabetes ... #DM2
Causes of Chronic Kidney Disease - Differential Diagnosis Algorithm
Decreased kidney function (eGFR < 60 ml/min/1.73 m2)
Differential Diagnosis Algorithm ... 60 ml/min/1.73 m2 ... Proteinuria) • Diabetes ... Hyperphosphatemia #CKD ... Differential #Diagnosis #Algorithm
Characteristics of Common Lipid Disorders
Polygenic hypercholesterolemia
Atherogenic dyslipidemia
 • Frequently accompanied by central obesity or diabetes
Familial hypercholesterolemia,
central obesity or diabetes ... Family history of CHD ... Dysbetalipoproteinemia (type ... Family history, CHD ... disorders #diseases #comparison
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... resynchronization therapy; DM ... , diabetes mellitus ... Stages #ACCAHA #Algorithm